Sign In
Buy DOX
Amdocs Earnings Calls
| Release date | May 13, 2026 |
| EPS estimate | $1.77 |
| EPS actual | $1.78 |
| EPS Surprise | 0.565% |
| Revenue estimate | 1.166B |
| Revenue actual | 1.172B |
| Revenue Surprise | 0.504% |
| Release date | Feb 03, 2026 |
| EPS estimate | $1.75 |
| EPS actual | $1.81 |
| EPS Surprise | 3.43% |
| Revenue estimate | 1.153B |
| Revenue actual | 1.156B |
| Revenue Surprise | 0.222% |
| Release date | Nov 11, 2025 |
| EPS estimate | $1.82 |
| EPS actual | $1.83 |
| EPS Surprise | 0.549% |
| Revenue estimate | 1.146B |
| Revenue actual | 1.15B |
| Revenue Surprise | 0.366% |
| Release date | Aug 06, 2025 |
| EPS estimate | $1.71 |
| EPS actual | $1.72 |
| EPS Surprise | 0.585% |
| Revenue estimate | 1.146B |
| Revenue actual | 1.144B |
| Revenue Surprise | -0.140% |
Last 4 Quarters for Amdocs
Below you can see how DOX performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 06, 2025 |
| Price on release | $84.57 |
| EPS estimate | $1.71 |
| EPS actual | $1.72 |
| EPS surprise | 0.585% |
| Date | Price |
|---|---|
| Jul 31, 2025 | $85.36 |
| Aug 01, 2025 | $84.49 |
| Aug 04, 2025 | $85.68 |
| Aug 05, 2025 | $84.79 |
| Aug 06, 2025 | $84.57 |
| Aug 07, 2025 | $88.87 |
| Aug 08, 2025 | $89.41 |
| Aug 11, 2025 | $86.45 |
| Aug 12, 2025 | $86.46 |
| 4 days before | -0.93% |
| 4 days after | 2.23% |
| On release day | 5.08% |
| Change in period | 1.29% |
| Release date | Nov 11, 2025 |
| Price on release | $83.96 |
| EPS estimate | $1.82 |
| EPS actual | $1.83 |
| EPS surprise | 0.549% |
| Date | Price |
|---|---|
| Nov 05, 2025 | $83.97 |
| Nov 06, 2025 | $83.66 |
| Nov 07, 2025 | $84.57 |
| Nov 10, 2025 | $85.49 |
| Nov 11, 2025 | $83.96 |
| Nov 12, 2025 | $77.36 |
| Nov 13, 2025 | $76.91 |
| Nov 14, 2025 | $77.74 |
| Nov 17, 2025 | $75.05 |
| 4 days before | -0.0119% |
| 4 days after | -10.61% |
| On release day | -7.86% |
| Change in period | -10.62% |
| Release date | Feb 03, 2026 |
| Price on release | $74.02 |
| EPS estimate | $1.75 |
| EPS actual | $1.81 |
| EPS surprise | 3.43% |
| Date | Price |
|---|---|
| Jan 28, 2026 | $81.82 |
| Jan 29, 2026 | $81.07 |
| Jan 30, 2026 | $81.94 |
| Feb 02, 2026 | $81.00 |
| Feb 03, 2026 | $74.02 |
| Feb 04, 2026 | $73.06 |
| Feb 05, 2026 | $71.13 |
| Feb 06, 2026 | $73.34 |
| Feb 09, 2026 | $73.35 |
| 4 days before | -9.53% |
| 4 days after | -0.91% |
| On release day | -1.30% |
| Change in period | -10.35% |
| Release date | May 13, 2026 |
| Price on release | $59.93 |
| EPS estimate | $1.77 |
| EPS actual | $1.78 |
| EPS surprise | 0.565% |
| Date | Price |
|---|---|
| May 07, 2026 | $65.14 |
| May 08, 2026 | $63.75 |
| May 11, 2026 | $62.57 |
| May 12, 2026 | $62.34 |
| May 13, 2026 | $59.93 |
| May 14, 2026 | $61.93 |
| May 15, 2026 | $60.58 |
| May 18, 2026 | $62.28 |
| May 19, 2026 | $62.09 |
| 4 days before | -8.00% |
| 4 days after | 3.60% |
| On release day | 3.34% |
| Change in period | -4.68% |
Amdocs Earnings Call Transcript Summary of Q1 2026
Amdocs delivered a solid start to fiscal 2026 with Q1 revenue of $1.156 billion (up 4.1% reported, 3.5% constant currency), non-GAAP diluted EPS of $1.81 (above guidance), and a 12-month backlog of $4.25 billion. Profitability improved modestly (non-GAAP operating margin 21.6%), and free cash flow before restructuring was strong at $237 million. Strategic highlights included a new multiyear (five-year) agreement with T-Mobile covering managed services, development and AI work (plus support for the UScellular integration), an expanded engagement with Vodafone Germany, and the close of the Matrix Software acquisition ($197 million) to strengthen billing/charging capabilities. Amdocs announced AOS, an agentic operating system purpose-built for telecommunications, positioned as a potential long-term growth engine tied to its Cognitive Core/GenAI strategy. Management reiterated FY26 guidance of constant-currency revenue growth of 1.5%–5.5% and non-GAAP diluted EPS growth of 4%–8%, and expects full-year free cash flow of $710M–$730M with most free cash flow to be returned to shareholders (dividends and buybacks). CEO Shuky Sheffer announced his planned retirement effective March 31, 2026, with Jimmy Olfic named successor, ensuring a planned leadership transition. Management emphasized continued measured investment in GenAI and cloud while balancing operational efficiencies and monitoring macro uncertainty.
